REQUEST A DEMO
Total
USD $0.00
Search more companies

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (China)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Profile Updated: November 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. is a biopharmaceutical company located in Huzhou. The company's main business is the research, production, and sales of allergen products. They continuously develop various desensitization therapy drugs and diagnostic reagents. The company has achieved a series of core technologies in the field of allergen products and has been granted 4 domestic invention patents and 1 European patent. Their independently developed products have received support from national high-tech industrialization projects and provincial key high-tech product plans. The series of desensitization drugs have filled the gap in the domestic market for sublingual desensitization drugs and allergen skin prick diagnostic reagents.

Headquarters
No. 636, Zhiyuan North Road, Wukang Town, Deqing County, Huzhou City, Zhejiang Province
Huzhou; Zhejiang; Postal Code: 200030

Contact Details: Purchase the Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.wolwobiotech.com

Basic Information
Total Employees:
Purchase the Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
September 19, 2002
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
38.86%
Purchase this report to view the information.
8.35%
Purchase this report to view the information.
4.98%
Purchase this report to view the information.
1.46%
Purchase this report to view the information.
1.37%
Subsidiaries
Shanghai Zhaomin Pharmaceutical Technology Co., Ltd.
100%
Wo Wu Pharmaceutical (Hong Kong) Co., Ltd.
100%
Zhejiang Super Soul Artificial Intelligence Research Institute Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
8.38%
Total operating revenue
9.1%
Operating profit (EBIT)
5.19%
Net Profit (Loss) for the Period
1.05%
Total assets
7.58%
Total equity
8.88%
Operating Profit Margin (ROS)
-1.31%
Net Profit Margin
-2.61%
Return on Equity (ROE)
-0.82%
Debt to Equity Ratio
0.86%
Quick Ratio
0.79%
Cash Ratio
0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?